How to Get Kalydeco (Ivacaftor) Covered by Humana in Michigan: Complete Appeals Guide with Forms and Timelines
Quick Answer: Getting Kalydeco Covered by Humana in Michigan
Kalydeco (ivacaftor) requires prior authorization from Humana and costs approximately $369,255 annually without coverage. To get approved: (1) Submit PA request with CFTR genetic testing showing responsive mutation (G551D, R117H, etc.), (2) Include specialist documentation from CF center, (3) If denied, file internal appeal within 65 days. For Humana Medicare members, external appeals go through federal review (MAXIMUS), not Michigan DIFS. Start today: Gather your genetic test results and contact your CF specialist to begin the PA process.
Table of Contents
- Understanding Kalydeco Coverage Requirements
- Step-by-Step: Fastest Path to Approval
- Common Denial Reasons & How to Fix Them
- Appeals Process for Humana in Michigan
- Medical Necessity Letter Template
- Costs and Patient Assistance
- When to Escalate and Get Help
- Frequently Asked Questions
Understanding Kalydeco Coverage Requirements
Kalydeco (ivacaftor) is a Tier 5 specialty medication on Humana formularies, meaning it requires prior authorization and specialized handling. The drug costs approximately $28,404 per 28-day supply ($369,255 annually) without insurance coverage.
Coverage at a Glance
| Requirement | What It Means | Where to Find It | Source |
|---|---|---|---|
| Prior Authorization Required | Must get approval before filling | Humana PA List | Humana Provider Portal |
| CFTR Mutation Documentation | Genetic test showing responsive mutation | Lab results from certified facility | FDA labeling requirements |
| Specialist Prescribing | CF specialist or pulmonologist required | Provider credentials verification | Humana policy guidelines |
| Age Requirements | FDA-approved for 1 month and older | Patient medical records | FDA Label |
| Formulary Tier | Tier 5 Specialty | Humana formulary lookup | Member portal |
Step-by-Step: Fastest Path to Approval
1. Confirm Your CFTR Mutation Status
Who does it: Patient works with CF specialist
Document needed: Genetic testing report showing responsive mutation
Timeline: 1-2 weeks if testing needed
Submit to: Keep for PA submission
Your doctor needs to confirm you have a CFTR mutation that responds to ivacaftor, such as G551D, R117H, or other FDA-approved responsive mutations.
2. Gather Required Clinical Documentation
Who does it: CF specialist and clinic staff
Documents needed:
- Current pulmonary function tests
- CF diagnosis confirmation with ICD-10 codes
- Prior treatment history
- Clinical notes supporting medical necessity
Timeline: 3-5 business days
Submit to: Include with PA request
3. Submit Prior Authorization Request
Who does it: Prescribing physician or authorized staff
How to submit: Humana provider portal (preferred) or fax to 1-877-486-2621
Timeline: Submit within 30 days of prescription
Expected response: 7 days standard, 72 hours expedited
Tip: Use Humana's online portal when possible—it's faster and provides real-time status updates.
4. Follow Up on Decision
Who does it: Patient or clinic staff
Timeline: Check status after 5 business days
Contact: Humana member services or provider portal
If approved, your prescription will be processed through Humana's specialty pharmacy network. If denied, proceed immediately to appeals.
Common Denial Reasons & How to Fix Them
| Denial Reason | How to Overturn | Required Documents |
|---|---|---|
| Missing genetic documentation | Submit complete CFTR testing results | Lab report showing specific mutation |
| Non-specialist prescriber | Transfer prescription to CF specialist | Provider NPI verification |
| Insufficient clinical justification | Submit detailed medical necessity letter | Pulmonary function data, symptom documentation |
| Age-related denial | Verify patient meets FDA age requirements | Birth certificate, medical records |
| Step therapy requirement | Document contraindications to alternatives | Clinical notes explaining why other treatments failed |
Appeals Process for Humana in Michigan
Internal Appeals (First Level)
Timeline: File within 65 days of denial notice
Decision timeframe: 7 days standard, 72 hours expedited
How to file: Written request to Humana appeals department
Include in your appeal:
- Original denial letter
- Medical necessity letter from CF specialist
- Complete CFTR genetic testing results
- Clinical documentation supporting treatment need
Federal External Review (Humana Medicare)
Important: Michigan DIFS cannot process external reviews for Humana Medicare plans. These go through federal review instead.
Timeline: File within 120 days of final internal denial
Decision timeframe: 60 days standard, 72 hours expedited
How to file: Contact MAXIMUS Federal Services
Contact Information:
- Phone: 1-888-866-6205
- Fax: 1-888-866-6190
- Email: [email protected]
- Online: externalappeal.cms.gov
Commercial Plan External Review
For non-Medicare Humana plans, Michigan's external review process applies:
Timeline: File within 127 days of final internal denial
Decision timeframe: 60 days standard, 72 hours expedited
Contact: Michigan DIFS
Phone: 877-999-6442
Medical Necessity Letter Template
When appealing a Kalydeco denial, your CF specialist should include these key elements:
Essential Components
Patient Information & Diagnosis
- Confirmed cystic fibrosis diagnosis with ICD-10 codes
- Specific CFTR mutation documented by genetic testing
- Age verification meeting FDA requirements
Clinical Justification
- Current symptoms and disease progression
- Pulmonary function trends showing need for intervention
- Previous treatments tried and outcomes
FDA Alignment
- Reference to FDA approval for patient's specific mutation
- Citation of clinical trial data supporting efficacy
- Explanation of mechanism of action for mutation type
Alternative Treatment Assessment
- Why other CFTR modulators are not appropriate
- Contraindications to step therapy requirements
- Specialist recommendation based on genotype
Sample Language
"Patient [Name] has confirmed cystic fibrosis with documented [specific mutation] CFTR mutation via genetic testing performed at [lab]. This mutation is FDA-approved for ivacaftor therapy per the current prescribing information. Clinical presentation includes [symptoms], with pulmonary function showing [data]. Previous treatments with [alternatives] resulted in [outcomes]. Based on the patient's specific genotype and clinical status, Kalydeco represents the most appropriate targeted therapy."
Costs and Patient Assistance
Financial Support Options
Vertex Patient Services Program
- Copay assistance for eligible patients
- Coverage investigation and prior authorization support
- Contact: 1-877-752-5933
Cystic Fibrosis Foundation Compass
- Insurance navigation assistance
- Appeals support and advocacy
- Contact: CF Foundation Compass
State Programs
- Michigan Medicaid may cover through managed care plans
- Healthy Michigan Plan for eligible adults
From our advocates: "We've seen patients successfully appeal Kalydeco denials by working closely with their CF center's social worker to gather all genetic testing documentation upfront. Having complete mutation analysis results—not just a summary—often makes the difference between approval and denial on the first submission."
When to Escalate and Get Help
Contact Michigan Insurance Regulators
If you're experiencing persistent coverage issues with a non-Medicare Humana plan:
Michigan Department of Insurance and Financial Services (DIFS)
- Phone: 877-999-6442
- Online complaint: michigan.gov/difs
- Email: [email protected]
Professional Advocacy
Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals. Their platform analyzes denial letters and plan policies to draft point-by-point rebuttals aligned to each payer's specific requirements, pulling the right clinical evidence and regulatory citations to support specialty drug approvals.
Legal Resources
For complex cases involving bad faith denials:
- Michigan State Bar Lawyer Referral Service
- Patient advocacy organizations
- Pro bono legal clinics
Frequently Asked Questions
How long does Humana prior authorization take for Kalydeco? Standard PA decisions are made within 7 days, expedited within 72 hours. Submit requests through the provider portal for fastest processing.
What if my CFTR mutation isn't on the approved list? Work with your CF specialist to document clinical rationale. Some mutations may qualify for off-label use coverage with strong medical necessity documentation.
Can I get expedited review if my condition is urgent? Yes. If delay would seriously jeopardize your health, request expedited PA and appeals. Your doctor must provide supporting documentation.
Does Humana require step therapy for Kalydeco? This varies by plan. If step therapy is required and other treatments are contraindicated, your doctor can request an exception.
What happens if I'm denied at every level? Consider manufacturer patient assistance programs, clinical trials, or working with advocacy organizations for additional appeal strategies.
How much will I pay out-of-pocket? As a Tier 5 specialty drug, expect higher copays. Exact amounts depend on your specific plan's cost-sharing structure.
Can my family member help with appeals? Yes, but you'll need to designate them as an authorized representative in writing to your insurance company.
What if I move to Michigan with existing Kalydeco coverage? Humana provides transition coverage for new members—typically 30 days—while you work through any coverage changes or PA requirements.
This article provides educational information only and is not medical advice. Always consult with your healthcare provider and insurance company for personalized guidance. Coverage policies and requirements may change.
Sources & Further Reading
- Humana Prior Authorization Lists
- FDA Kalydeco Prescribing Information
- Michigan DIFS External Review Process
- MAXIMUS Federal External Review
- Cystic Fibrosis Foundation Resources
- Vertex Patient Support Programs
Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.